As the activity and differentiation of CD8+ T cells are regulated by different metabolic programmes, previous studies have focused on cancer and T cell metabolism to uncover vulnerabilities that can be exploited as new therapeutic options14,15. This evidence concerns the gene CD8A and cancer.